Task Order 11- Nonclinical Toxicology Study of an investigational agent in development for anticancer therapy
$8,438N01FY2014CANIH
Iit Research Institute, Chicago IL
Investigators
Abstract
Test agents are being considered for development as an anticancer therapeutics. To generate information to identify drugs with the potential to treat cancer, maintenance of test systems for a defined period of time was required.
View original record on NIH RePORTER →